10x Genomics (FRA:1KJ) Gross-Profit-to-Asset % : 47.88% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is 10x Genomics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. 10x Genomics's annualized Gross Profit for the quarter that ended in Dec. 2023 was €424.7 Mil. 10x Genomics's average Total Assets over the quarter that ended in Dec. 2023 was €886.9 Mil. Therefore, 10x Genomics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 47.88%.

10x Genomics Gross-Profit-to-Asset % Historical Data

The historical data trend for 10x Genomics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Gross-Profit-to-Asset % Chart

10x Genomics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

50.83

30.18

44.25

39.92

40.44

10x Genomics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															45.60	38.32	39.53	39.73	47.88

Competitive Comparison of 10x Genomics's Gross-Profit-to-Asset %

For the Health Information Services subindustry, 10x Genomics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10x Genomics's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where 10x Genomics's Gross-Profit-to-Asset % falls into.

10x Genomics Gross-Profit-to-Asset % Calculation

10x Genomics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	375.34	/	( (971.357	+	885.036)	/ 2 )
	=	375.34	/	928.1965
	=	40.44 %

10x Genomics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	424.688	/	( (888.782	+	885.036)	/ 2 )
	=	424.688	/	886.909
	=	47.88 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

10x Genomics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

10x Genomics (FRA:1KJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (FRA:1KJ) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

TXG:USA 1KJ:Germany

Address

6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588

Website

https://www.10xgenomics.com

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10x Genomics (FRA:1KJ) Headlines

No Headlines